KF
Kelsey Financial, LLC
13F filer · CIK 0002022609Reported Aug 10, 2026
Net buyer this quarter
13F portfolio value$132MU.S. long equity reported on 13F
Positions385 new · 3 closed
Net flow last quarter+$1.23MBuys minus sells
Top 10 positions weight45.7%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 10, 202638 positions | |||||
| $27.5M | 20.90% | Not reported | +2.1% | Q4 2025 | |
| $8.99M | 6.82% | 0.00% | Not reported | Q4 2025 | |
| $7.89M | 5.99% | 0.00% | 0.0% | Q4 2025 | |
| $5.93M | 4.50% | Not reported | +1.6% | Q4 2025 | |
| $3.28M | 2.49% | Not reported | -8.5% | Q4 2025 | |
| $2.11M | 1.60% | 0.00% | +1.6% | Q4 2025 | |
| $1.56M | 1.18% | 0.00% | +0.6% | Q4 2025 | |
| $1.23M | 0.93% | 0.00% | -0.2% | Q4 2025 | |
| $972K | 0.74% | 0.00% | Not reported | Q4 2025 | |
| $786K | 0.60% | 0.00% | -1.3% | Q4 2025 | |
| $771K | 0.59% | 0.00% | +1.2% | Q4 2025 | |
| $609K | 0.46% | 0.00% | +0.2% | Q4 2025 | |
| $580K | 0.44% | 0.00% | Not reported | Q4 2025 | |
| $550K | 0.42% | 0.00% | Not reported | Q4 2025 | |
| $458K | 0.35% | 0.00% | Not reported | Q4 2025 | |
| $435K | 0.33% | 0.00% | Not reported | Q4 2025 | |
| $431K | 0.33% | 0.00% | -1.1% | Q4 2025 | |
| $426K | 0.32% | 0.00% | Not reported | Q4 2025 | |
| $337K | 0.26% | Not reported | +10.8% | Q4 2025 | |
| $334K | 0.25% | 0.00% | -1.1% | Q1 2026 | |
| $329K | 0.25% | 0.00% | -4.8% | Q4 2025 | |
| $307K | 0.23% | 0.00% | Not reported | Q4 2025 | |
| $289K | 0.22% | 0.00% | Not reported | Q4 2025 | |
| $282K | 0.21% | 0.00% | New | Q2 2026 | |
| $279K | 0.21% | 0.00% | Not reported | Q4 2025 | |
| $256K | 0.19% | 0.00% | Not reported | Q4 2025 | |
| $253K | 0.19% | 0.01% | Not reported | Q4 2025 | |
| $250K | 0.19% | 0.00% | -0.1% | Q4 2025 | |
| $228K | 0.17% | 0.00% | +11.8% | Q1 2026 | |
| $227K | 0.17% | 0.00% | New | Q2 2026 | |
| $226K | 0.17% | Not reported | New | Q2 2026 | |
| $223K | 0.17% | 0.00% | Not reported | Q4 2025 | |
| $215K | 0.16% | 0.00% | +7.3% | Q1 2026 | |
| $214K | 0.16% | 0.00% | New | Q2 2026 | |
| $204K | 0.15% | 0.00% | New | Q2 2026 | |
| $191K | 0.15% | 0.00% | Not reported | Q4 2025 | |
| $82K | 0.06% | 0.06% | +8.8% | Q4 2025 | |
| $9.69K | 0.01% | 0.49% | +37.0% | Q4 2025 | |
| Q1 2026Reported May 6, 202636 positions | |||||
| $21.1M | 18.49% | Not reported | +15.6% | Q4 2025 | |
| $7.67M | 6.71% | 0.00% | 0.0% | Q4 2025 | |
| $7.37M | 6.44% | 0.00% | -5.9% | Q4 2025 | |
| $5.17M | 4.52% | Not reported | -8.1% | Q4 2025 | |
| $3.12M | 2.73% | Not reported | +7.3% | Q4 2025 | |
| $1.82M | 1.59% | 0.00% | -3.9% | Q4 2025 | |
| $1.35M | 1.18% | 0.00% | +2.5% | Q4 2025 | |
| $1.09M | 0.95% | 0.00% | -7.1% | Q4 2025 | |
| $834K | 0.73% | 0.00% | Not reported | Q4 2025 | |
| $790K | 0.69% | 0.00% | +0.3% | Q4 2025 | |
| $784K | 0.69% | 0.00% | -2.3% | Q4 2025 | |
| $568K | 0.50% | 0.00% | Not reported | Q4 2025 | |
| $567K | 0.50% | 0.00% | +0.1% | Q4 2025 | |
| $444K | 0.39% | 0.00% | -8.7% | Q4 2025 | |
| $410K | 0.36% | 0.00% | -16.7% | Q4 2025 | |
| $388K | 0.34% | 0.00% | Not reported | Q4 2025 | |
| $368K | 0.32% | 0.00% | +4.4% | Q4 2025 | |
| $331K | 0.29% | 0.00% | -22.4% | Q4 2025 | |
| $331K | 0.29% | 0.00% | +0.4% | Q4 2025 | |
| $302K | 0.26% | 0.00% | +0.4% | Q4 2025 | |
| $279K | 0.24% | 0.00% | Not reported | Q4 2025 | |
| $274K | 0.24% | 0.00% | Not reported | Q4 2025 | |
| $251K | 0.22% | 0.00% | New | Q1 2026 | |
| $250K | 0.22% | 0.00% | Not reported | Q4 2025 | |
| $247K | 0.22% | Not reported | +0.6% | Q4 2025 | |
| $241K | 0.21% | 0.00% | +0.4% | Q4 2025 | |
| $238K | 0.21% | 0.00% | New | Q1 2026 | |
| $230K | 0.20% | 0.00% | Not reported | Q4 2025 | |
| $223K | 0.19% | 0.01% | Not reported | Q4 2025 | |
| $220K | 0.19% | 0.00% | Not reported | Q4 2025 | |
| $212K | 0.19% | 0.00% | New | Q1 2026 | |
| $200K | 0.18% | 0.00% | New | Q1 2026 | |
| $173K | 0.15% | 0.00% | -2.9% | Q4 2025 | |
| $79.6K | 0.07% | 0.06% | +7.1% | Q4 2025 | |
| STSGMOQSangamo Therapeutics, Inc | $10.4K | 0.01% | 0.01% | +20.0% | Q4 2025 |
| $9.45K | 0.01% | 0.01% | +125.0% | Q4 2025 | |
| Q4 2025Reported Jan 23, 202634 positions | |||||
| $19.5M | 16.72% | Not reported | New | Q4 2025 | |
| $8.76M | 7.52% | 0.00% | New | Q4 2025 | |
| $7.13M | 6.13% | 0.00% | New | Q4 2025 | |
| $5.44M | 4.68% | Not reported | New | Q4 2025 | |
| $3.05M | 2.62% | Not reported | New | Q4 2025 | |
| $2.03M | 1.74% | 0.00% | New | Q4 2025 | |
| $1.42M | 1.22% | 0.00% | New | Q4 2025 | |
| $1.41M | 1.21% | 0.00% | New | Q4 2025 | |
| $1.03M | 0.88% | 0.00% | New | Q4 2025 | |
| $995K | 0.86% | 0.00% | New | Q4 2025 | |
| $680K | 0.58% | 0.00% | New | Q4 2025 | |
| $593K | 0.51% | 0.00% | New | Q4 2025 | |
| $576K | 0.49% | 0.00% | New | Q4 2025 | |
| $403K | 0.35% | 0.00% | New | Q4 2025 | |
| $371K | 0.32% | 0.00% | New | Q4 2025 | |
| $370K | 0.32% | 0.00% | New | Q4 2025 | |
| $358K | 0.31% | 0.00% | New | Q4 2025 | |
| $350K | 0.30% | 0.00% | New | Q4 2025 | |
| $346K | 0.30% | 0.00% | New | Q4 2025 | |
| $333K | 0.29% | 0.00% | New | Q4 2025 | |
| $333K | 0.29% | 0.00% | New | Q4 2025 | |
| $269K | 0.23% | Not reported | New | Q4 2025 | |
| $267K | 0.23% | 0.01% | New | Q4 2025 | |
| $242K | 0.21% | 0.00% | New | Q4 2025 | |
| $220K | 0.19% | 0.00% | New | Q4 2025 | |
| $220K | 0.19% | 0.00% | New | Q4 2025 | |
| $218K | 0.19% | 0.00% | New | Q4 2025 | |
| $206K | 0.18% | 0.00% | New | Q4 2025 | |
| $203K | 0.17% | 0.00% | New | Q4 2025 | |
| $203K | 0.17% | 0.00% | New | Q4 2025 | |
| $178K | 0.15% | 0.00% | New | Q4 2025 | |
| $92.8K | 0.08% | 0.05% | New | Q4 2025 | |
| STSGMOQSangamo Therapeutics, Inc | $14.7K | 0.01% | 0.01% | New | Q4 2025 |
| $3.6K | 0.00% | 0.01% | New | Q4 2025 | |
Premium opens every quarter this fund has filed